176 related articles for article (PubMed ID: 29442546)
1. VEGF therapy for the kidney: emerging strategies.
Guise E; Chade AR
Am J Physiol Renal Physiol; 2018 Oct; 315(4):F747-F751. PubMed ID: 29442546
[TBL] [Abstract][Full Text] [Related]
2. Role of renal microcirculation in experimental renovascular disease.
Iliescu R; Fernandez SR; Kelsen S; Maric C; Chade AR
Nephrol Dial Transplant; 2010 Apr; 25(4):1079-87. PubMed ID: 19934087
[TBL] [Abstract][Full Text] [Related]
3. Systemic biopolymer-delivered vascular endothelial growth factor promotes therapeutic angiogenesis in experimental renovascular disease.
Chade AR; Williams ML; Guise E; Vincent LJ; Harvey TW; Kuna M; Mahdi F; Bidwell GL
Kidney Int; 2018 Apr; 93(4):842-854. PubMed ID: 29273331
[TBL] [Abstract][Full Text] [Related]
4. Reversal of renal dysfunction by targeted administration of VEGF into the stenotic kidney: a novel potential therapeutic approach.
Chade AR; Kelsen S
Am J Physiol Renal Physiol; 2012 May; 302(10):F1342-50. PubMed ID: 22357917
[TBL] [Abstract][Full Text] [Related]
5. Renal Therapeutic Angiogenesis Using a Bioengineered Polymer-Stabilized Vascular Endothelial Growth Factor Construct.
Chade AR; Tullos NA; Harvey TW; Mahdi F; Bidwell GL
J Am Soc Nephrol; 2016 Jun; 27(6):1741-52. PubMed ID: 26541349
[TBL] [Abstract][Full Text] [Related]
6. Recovery of Renal Function following Kidney-Specific VEGF Therapy in Experimental Renovascular Disease.
Engel JE; Williams ML; Williams E; Azar C; Taylor EB; Bidwell GL; Chade AR
Am J Nephrol; 2020; 51(11):891-902. PubMed ID: 33130676
[TBL] [Abstract][Full Text] [Related]
7. Biopolymer-delivered vascular endothelial growth factor improves renal outcomes following revascularization.
Guise E; Engel JE; Williams ML; Mahdi F; Bidwell GL; Chade AR
Am J Physiol Renal Physiol; 2019 May; 316(5):F1016-F1025. PubMed ID: 30892933
[TBL] [Abstract][Full Text] [Related]
8. Kidney vasculogenesis and angiogenesis: role of vascular endothelial growth factor.
Del Porto F; Mariotti A; Ilardi M; Messina FR; Afeltra A; Amoroso A
Eur Rev Med Pharmacol Sci; 1999; 3(4):149-53. PubMed ID: 11073120
[TBL] [Abstract][Full Text] [Related]
9. Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use?
Chade AR; Stewart N
J Am Soc Hypertens; 2013; 7(2):180-90. PubMed ID: 23428409
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal Stem Cell-Derived Extracellular Vesicles Improve the Renal Microvasculature in Metabolic Renovascular Disease in Swine.
Eirin A; Zhu XY; Jonnada S; Lerman A; van Wijnen AJ; Lerman LO
Cell Transplant; 2018 Jul; 27(7):1080-1095. PubMed ID: 29954220
[TBL] [Abstract][Full Text] [Related]
11. The Metabolic Syndrome Does Not Affect Development of Collateral Circulation in the Poststenotic Swine Kidney.
Zhang X; Kim SR; Ferguson CM; Ebrahimi B; Hedayat AF; Lerman A; Lerman LO
Am J Hypertens; 2018 Nov; 31(12):1307-1316. PubMed ID: 30107490
[TBL] [Abstract][Full Text] [Related]
12. Renovascular disease, microcirculation, and the progression of renal injury: role of angiogenesis.
Chade AR
Am J Physiol Regul Integr Comp Physiol; 2011 Apr; 300(4):R783-90. PubMed ID: 21307362
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis in the kidney: a new therapeutic target?
Lerman LO; Chade AR
Curr Opin Nephrol Hypertens; 2009 Mar; 18(2):160-5. PubMed ID: 19430335
[TBL] [Abstract][Full Text] [Related]
14. Restoring the renal microvasculature to treat chronic kidney disease.
Long DA; Norman JT; Fine LG
Nat Rev Nephrol; 2012 Feb; 8(4):244-50. PubMed ID: 22310952
[TBL] [Abstract][Full Text] [Related]
15. Endothelial progenitor cells restore renal function in chronic experimental renovascular disease.
Chade AR; Zhu X; Lavi R; Krier JD; Pislaru S; Simari RD; Napoli C; Lerman A; Lerman LO
Circulation; 2009 Feb; 119(4):547-57. PubMed ID: 19153272
[TBL] [Abstract][Full Text] [Related]
16. Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease.
Kang DH; Anderson S; Kim YG; Mazzalli M; Suga S; Jefferson JA; Gordon KL; Oyama TT; Hughes J; Hugo C; Kerjaschki D; Schreiner GF; Johnson RJ
Am J Kidney Dis; 2001 Mar; 37(3):601-11. PubMed ID: 11228186
[TBL] [Abstract][Full Text] [Related]
17. Vascular Endothelial Growth Factor and Podocyte Protection in Chronic Hypoxia: Effects of Endothelin-A Receptor Antagonism.
Harvey TW; Engel JE; Chade AR
Am J Nephrol; 2016; 43(2):74-84. PubMed ID: 26930122
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide modulates vascular disease in the remnant kidney model.
Kang DH; Nakagawa T; Feng L; Johnson RJ
Am J Pathol; 2002 Jul; 161(1):239-48. PubMed ID: 12107108
[TBL] [Abstract][Full Text] [Related]
19. Microvascular remodeling and altered angiogenic signaling in human kidneys distal to occlusive atherosclerotic renal artery stenosis.
Klomjit N; Zhu XY; Eirin A; Pawar AS; Conley SM; Puranik AS; Ferguson CM; Kim SR; Tang H; Jordan KL; Saadiq IM; Lerman A; Grande JP; Textor SC; Lerman LO
Nephrol Dial Transplant; 2022 Sep; 37(10):1844-1856. PubMed ID: 35451482
[TBL] [Abstract][Full Text] [Related]
20. Autologous Mesenchymal Stem Cells Increase Cortical Perfusion in Renovascular Disease.
Saad A; Dietz AB; Herrmann SMS; Hickson LJ; Glockner JF; McKusick MA; Misra S; Bjarnason H; Armstrong AS; Gastineau DA; Lerman LO; Textor SC
J Am Soc Nephrol; 2017 Sep; 28(9):2777-2785. PubMed ID: 28461553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
